Mechanisms (known and unknown)Intragenic recombination (Bloom syndrome) Mitotic gene conversion (epidermolysis bullosa COL17A1) Second site suppressor mutations (in same gene or different gene) Site specific insertion→deletion or vice versa of repeat Site specific insertion/deletion of single nucleotide in nucleotide run (slippage) Expansion/contraction of repeat Site specific single nucleotide reversion (homozygous or hemizygous originally)
|
Gross effect on phenotype in vivo (modifies ascertainnment)Milder manifestations Slows/abolishes progression of disease Normal areas in vivo (e.g. skin) Normalization of types of cells in blood (+/−disease amelioration) No effect observed in vivo
|
Effect on cells/tisssue; histology, cell protein cell function: (with or without out culturing in vitro)Reversion to normal function Reversion to presence of protein without function Tissue involved (modifies ascertainment)
|
Specific genetic disorders |